Professor and Chief of the Division of Hematology/Oncology in the Department of Internal Medicine at the UNM School of Medicine and Health Sciences Center Robert Hromas will talk on "Repurposing Drugs for Commercialization" on Thursday, Oct. 21 at 12 p.m. in the Domenici Education Center West, Room 3010 on the UNM North Campus.
Most cancer chemotherapy and radiation therapy kills cancer by damaging their DNA and preventing DNA replication. However, cancer cells have DNA repair and replication proteins such as Metnasa and Intnase that help cancer cells resist the therapy by increasing their ability to repair and replicate. Hromas will talk about his research in this area, and the discovery of repurposing capabilities of an HIV drug for cancer treatment. His ongoing research has led to the development of new inhibitors for Metnase and Intnase.
STC.UNM is sponsoring the lecture as part of its fall lecture series. The seminars are free and open to the UNM community, but registration is required. To register contact Denise Bissell at (505) 272‑7310 or email@example.com
Media contact: Karen Wentworth (505) 277-5627; e-mail: firstname.lastname@example.org